Skip to content

13F-HR filed by Eagle Health Investments LP

Eagle Health Investments LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-04, with 24 holding rows worth $156,340,000.

Accession
0001842545-21-000002
Filed
2021-02-04
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 24 entries on the cover page, a total value of $156,340,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $156,338,000 with VALUE read as thousands by filing date, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IQVIA HLDGS INC COM46266C105Stock72,377$12,968,000thousands by filing date
HUMANA INC COM444859102Stock31,162$12,785,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM52,000$12,290,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM24,851$11,575,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR230,100$11,503,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock85,793$11,151,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock70,000$10,625,000thousands by filing date
AXONICS INC05465P101COM182,840$9,127,000thousands by filing date
NATERA INC COM632307104Stock78,600$7,822,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM62,060$6,960,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM42,929$6,707,000thousands by filing date
ILLUMINA INC452327109COM15,700$5,809,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR19,587$5,760,000thousands by filing date
DEXCOM INC COM252131107Stock13,800$5,102,000thousands by filing date
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock83,535$4,939,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock32,460$4,183,000thousands by filing date
OUTSET MEDICAL INC690145107COM72,000$4,092,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM69,700$3,020,000thousands by filing date
JAWS ACQUISITION CORPG50744104SHS188,300$2,525,000thousands by filing date
LONGVIEW ACQUISITION CORP543195101COM CL A114,100$2,258,000thousands by filing date
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock50,000$2,073,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM69,000$1,520,000thousands by filing date
SEER INC81578P106COM CL A20,000$1,123,000thousands by filing date
DEERFIELD HEALTHCARE TECH AC244413100COM CL A27,008$421,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001842545-21-000002this filing2021-02-04acceptance time not in the bulk data set